Clinical Value of G-EYE Colonoscopy in Daily Practice for Adenoma Detection and Time for Polyp Removal
1 other identifier
observational
2,795
1 country
1
Brief Summary
Colonoscopy parameters will be compared before the introduction of the G-EYE endoscope and after the introduction of the G-EYE endoscope
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 18, 2021
CompletedFirst Posted
Study publicly available on registry
February 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedOctober 22, 2021
October 1, 2021
1.1 years
February 18, 2021
October 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Detection rate - measured by adenoma detection rate (% subjects having at least 1 adenoma)
G-EYE® colonoscopy adenoma detection rate compared to adenoma detection rate of standard colonoscopy
February 2021
Effectiveness of intervention - measured by polyp removal time (mm:ss)
G-EYE® colonoscopy polyp removal time compared to polyp removal time of standard colonoscopy
February 2021
Study Arms (2)
Standard Colonoscopy
Colonoscopy with a standard colonoscope
G-EYE® Colonoscopy
Colonoscopy with a G-EYE Colonoscopy
Interventions
Eligibility Criteria
Screening and surveillance colonoscopy patients
You may qualify if:
- \- Indication for screening or surveillance colonoscopy based on the German guideline for colon cancer screening
You may not qualify if:
- Emergency procedure
- Patients with known inflammatory bowel diseases
- Patients with hereditary cancer syndromes
- Patients with acute colonic inflammation (e.g. diverticulitis, ischemic colitis)
- Patients after radiation of the abdomen or pelvis
- Patients with colonic surgery (except appendectomy)
- Patients with incomplete colonoscopy
- Patients with insufficient bowel preparation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helios Dr. Horst Schmidt Kliniken
Wiesbaden, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ralf Kiesslich, Prof.
Helios Dr. Horst Schmidt Kliniken Wiesbaden
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
February 18, 2021
First Posted
February 23, 2021
Study Start
March 1, 2020
Primary Completion
April 1, 2021
Study Completion
May 1, 2021
Last Updated
October 22, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share